Rubra Medicaments Limited reported earnings results for the full year ended March 31, 2022. For the full year, the company reported sales was INR 20.11 million compared to INR 4.85 million a year ago. Revenue was INR 20.12 million compared to INR 4.85 million a year ago. Net loss was INR 0.365 million compared to net income of INR 0.057 million a year ago.